Investments

Buyout

Envision Pharma

United-KIngdom

06 July 2016

Healthcare & life science

Exited 04 November 2020

Healthcare & life science

Envision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies. Envision currently has ten offices, three in the United Kingdom, five in the United States, two in Asia Pacific, and employs around 450 team members.

Deal team

Bruno Ladrière

Benjamin Witcher

Press releases

Ardian & GHO captital team with envision leadership to acquire the Envision Pharma group from the Halifax Group

https://www.envisionpharmagroup.com/

https://twitter.com/EnvisionPharma

https://www.linkedin.com/company/envision-pharma-group

We appreciate Ardian’s unique support on our growth path that helped us very much to become market leader and position us ideally for future growth.”

Daniel Schustermann Managing Director of Schustermann & Borenstein

It is an efficient team, determined and confident in its choices, and always attentive to its partners. The relationships of trust that the Ardian team builds over time, with the management teams and, beyond that, with the advisors around them, are part of their DNA.

David Aknin Lawyer

Buyout

Expertise
Buyout

Team

Investments

Envision Pharma

Deal team

Press releases